“Efficacy of daclatasvir plus peginterferon alfa and ribavirin for patients with chronic hepatitis C genotype 4 infection”, Bangladesh J Pharmacol, vol. 12, no. 1, pp. 12–22, Mar. 2017, doi: 10.3329/bjp.v12i1.29940.